Comparing Nasopharyngeal and Midturbinate Nasal Swab Testing for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 | Zendy

Swetha Pinninti | Zendy; Connie Trieu | Zendy; Sunil Pati | Zendy; Misty Latting | Zendy; Joshua Cooper | Zendy; Maria C. Seleme | Zendy; Sushma Boppana | Zendy; Nitin Arora | Zendy; William J. Britt | Zendy; Suresh B. Boppana | Zendy

Open Access

Comparing Nasopharyngeal and Midturbinate Nasal Swab Testing for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2

Author(s) -

Swetha Pinninti,

Connie Trieu,

Sunil Pati,

Misty Latting,

Joshua Cooper,

Maria C. Seleme,

Sushma Boppana,

Nitin Arora,

William J. Britt,

Suresh B. Boppana

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa882

Subject(s) - medicine , covid-19 , coronavirus , respiratory system , virology , disease , infectious disease (medical specialty) , outbreak

Testing of paired midturbinate (MT) nasal and nasopharyngeal (NP) swabs, collected by trained personnel from 40 patients with coronavirus disease 2019 (COVID-19), showed that more NP (76/95 [80%]) than MT swabs tested positive (61/95 [64%]) (P = .02). Among samples collected a week after study enrollment, fewer MT than NP samples were positive (45% vs 76%; P = .001).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research